Methyl-parathion hydrolase49
|
25 (32) |
Catalytic activity |
β-lactamase51
|
25 (32) |
Antibiotics resistance (minimum antibiotics conc. inhibiting growth) |
Dihydrofolate reductase3
|
3 × 24 (48) |
Antibiotics resistance (antibiotics conc. reducing growth rate by 75%) |
Influenza A H3N2 hemagglutinin41
|
22 × 32 × 42 (576) |
Viral replication fitness |
Antibody CR626119
|
211 (2,048) |
Affinity for influenza hemagglutinin strain H1 or H9 |
Bacterial antitoxin ParD352
|
203 (8000) |
Fitness conferred by binding to toxin ParE3 or ParE2 |
Aequorea victoria GFP (avGFP)15
|
213 (8192) |
Fluorescence |
Bacterial antitoxin ParD353
|
13 × 12 × 10 × 6 (9360) |
Fitness conferred by binding to toxin ParE3 or ParE2 |
SARS-CoV-2 spike protein7
|
215 (32,768) |
Affinity for human ACE2 |
Antibody CH6520
|
216 (65,536) |
Affinity for influenza hemagglutinin strain MA90, MA90-G189E, or SI06 |
Antibody CR911419
|
216 (65,536) |
Affinity for influenza hemagglutinin strain B, H1, or H3 |
Transcription factor ParB50
|
204 (160,000) |
Fitness conferred by transcription |
Protein G B1 domain (GB1)12
|
204 (160,000) |
Binding enrichment for IgG-Fc |